Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ironwood Pharmaceuticals to Participate in Upcoming September Investor Conferences By: Ironwood Pharmaceuticals, Inc. via Business Wire September 02, 2021 at 07:30 AM EDT Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will participate in fireside chats at two upcoming virtual investor conferences in September: 2021 Wells Fargo Healthcare Conference on Friday, September 10, 2021 at 2:00 p.m. ET Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021 at 2:45 p.m. ET A live webcast of Ironwood’s fireside chats will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com. To access the webcasts, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcasts will be available on Ironwood’s website for 14 days following the conference. About Ironwood Pharmaceuticals Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI-focused healthcare company dedicated to creating medicines that make a difference for patients living with GI diseases. We discovered, developed and are commercializing linaclotide, the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Ironwood was founded in 1998 and is headquartered in Boston, Mass. For more information, please visit our website at www.ironwoodpharma.com or www.twitter.com/ironwoodpharma; information that may be important to investors will be routinely posted in both these locations. View source version on businesswire.com: https://www.businesswire.com/news/home/20210902005017/en/Contacts Investors: Matt Roache, 617-621-8395 Director, Investor Relations mroache@ironwoodpharma.com Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
Ironwood Pharmaceuticals to Participate in Upcoming September Investor Conferences By: Ironwood Pharmaceuticals, Inc. via Business Wire September 02, 2021 at 07:30 AM EDT Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will participate in fireside chats at two upcoming virtual investor conferences in September: 2021 Wells Fargo Healthcare Conference on Friday, September 10, 2021 at 2:00 p.m. ET Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021 at 2:45 p.m. ET A live webcast of Ironwood’s fireside chats will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com. To access the webcasts, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcasts will be available on Ironwood’s website for 14 days following the conference. About Ironwood Pharmaceuticals Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI-focused healthcare company dedicated to creating medicines that make a difference for patients living with GI diseases. We discovered, developed and are commercializing linaclotide, the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Ironwood was founded in 1998 and is headquartered in Boston, Mass. For more information, please visit our website at www.ironwoodpharma.com or www.twitter.com/ironwoodpharma; information that may be important to investors will be routinely posted in both these locations. View source version on businesswire.com: https://www.businesswire.com/news/home/20210902005017/en/Contacts Investors: Matt Roache, 617-621-8395 Director, Investor Relations mroache@ironwoodpharma.com
Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will participate in fireside chats at two upcoming virtual investor conferences in September: 2021 Wells Fargo Healthcare Conference on Friday, September 10, 2021 at 2:00 p.m. ET Morgan Stanley 19th Annual Global Healthcare Conference on Monday, September 13, 2021 at 2:45 p.m. ET A live webcast of Ironwood’s fireside chats will be accessible through the Investors section of the company’s website at www.ironwoodpharma.com. To access the webcasts, please log on to the Ironwood website approximately 15 minutes prior to the start time to ensure adequate time for any software downloads that may be required. A replay of the webcasts will be available on Ironwood’s website for 14 days following the conference. About Ironwood Pharmaceuticals Ironwood Pharmaceuticals (Nasdaq: IRWD) is a GI-focused healthcare company dedicated to creating medicines that make a difference for patients living with GI diseases. We discovered, developed and are commercializing linaclotide, the U.S. branded prescription market leader for adults with irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC). Ironwood was founded in 1998 and is headquartered in Boston, Mass. For more information, please visit our website at www.ironwoodpharma.com or www.twitter.com/ironwoodpharma; information that may be important to investors will be routinely posted in both these locations. View source version on businesswire.com: https://www.businesswire.com/news/home/20210902005017/en/